Effect of SDDS (2-'sulfamonyl-4,4'-diamino diphenylsulphone) on experimental infection with Toxoplasma gondii in rabbits.
D000818:Animals; D000917:Antibody Formation; D003622:Dapsone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D008297:Male; D011817:Rabbits; D013424:Sulfanilamides / Q000627:therapeutic use; D014122:Toxoplasma / Q000276:immunology; D014124:Toxoplasmosis, Animal / Q000188:drug therapy* / Q000276:immunology
D013424:Sulfanilamides; C003361:SDDS; D003622:Dapsone